Wall Street's Favorite New AI Stock vs. the One They're Ignoring: The Numbers Aren't Even Close

Cerebras jumped 68% on its first day of trading and is now about 60% above its $185 IPO price, but the article argues the rally is ahead of fundamentals. Cerebras generated just $500 million in 2025 sales and a non-GAAP loss of nearly $76 million, versus Microsoft’s nearly $83 billion in quarterly revenue and $4.27 in adjusted EPS. The piece is broadly bullish on AI but cautions that investor enthusiasm for Cerebras may be premature relative to Microsoft’s stronger, already-monetizing AI position.

Analysis

The market is paying up for narrative optionality in Cerebras while underweighting the more important second-order effect: if the AI capex cycle stays concentrated in a few hyperscalers, the beneficiaries with distribution, cash flow, and software attach rates should keep compounding even if hardware enthusiasm rotates. That makes MSFT the cleaner expression of AI monetization over the next 12-24 months, because its earnings quality is improving while its valuation discount reflects fatigue, not deteriorating fundamentals.

Cerebras is interesting less as a near-term earnings story and more as a call option on AI infrastructure diversification. The equity could stay volatile for months because the OpenAI ties give it a powerful financing and credibility loop, but the setup also creates binary downside if deployment milestones slip or if customers treat it as a niche supplement rather than a true Nvidia alternative. The real risk is that investors are capitalizing a multi-year TAM story on today’s revenue base, which leaves little margin for execution error.

The contrarian read is that the crowd is mixing up "strategic relevance" with "stock quality." Nvidia remains the default benefactor of AI spend; Cerebras may win pockets of demand, but that does not automatically translate into durable scale economics. Microsoft, by contrast, is the more underappreciated beneficiary because every incremental AI workload routed through Azure and Copilot improves both revenue mix and stickiness, while the balance sheet gives it the ability to absorb any temporary model- or chip-cycle volatility.

Near term, the setup favors a relative-value trade rather than outright beta: the speculative IPO trade in CBRS can persist for weeks, but MSFT’s fundamentals should reassert over a 1-2 quarter horizon if cloud growth stays high-30s/low-40s. The key catalyst to watch is whether Cerebras can convert headline partnerships into visible backlog and utilization; absent that, the stock becomes increasingly vulnerable to a post-lockup or post-hype derating.

Key Decisions for Investors

• Long MSFT on a 3-6 month horizon; use weakness below recent trading range to build. Risk/reward favors a rerating as AI and Azure cash flow visibility stays strong, with downside cushioned by balance sheet and recurring revenue.
• Fade CBRS strength tactically: initiate a small short or buy puts into post-IPO momentum if borrow/liquidity allow. Best used as a trade-on-news with a tight stop, because the stock can remain momentum-driven for weeks.
• Pair trade: long MSFT / short CBRS. This isolates the market’s overpayment for narrative versus a proven AI monetizer; target a 10-20% relative move over 1-2 quarters if execution gaps persist.
• If seeking AI upside with better asymmetry than CBRS, rotate toward NVDA on dips rather than chasing the upstart. NVDA retains the dominant share of AI data-center spend, so any short-term supply chain noise is less important than demand durability.
• Set a catalyst watch on Cerebras operating milestones over the next 1-2 quarters; if revenue conversion from strategic deals is not visible, reduce or exit any bullish exposure quickly because the valuation is almost entirely expectation-driven.